p53 monitors genomic integrity at the G1 and G2/M cell cycle checkpoints. Cells lacking p53 may show gene ampli®cation as well as the polyploidy or aneuploidy typical of many tumors. The pathways through which this develops, however, are not well de®ned. We demonstrate here that the combination of p53 inactivation and c-myc overexpression in diploid cells markedly accelerates the spontaneous development of tetraploidy. This is not seen with either N-myc or L-myc. Tetraploidy is accompanied by signi®cantly higher levels of cyclin B and its associated cdc2 kinase activity. Mitotic spindle poisons accelerate the appearance of tetraploidy in cells either lacking functional p53 or overexpressing c-myc whereas the combination is additive. Restoration of p53 function in cells overexpressing c-myc causing rapid apoptosis, indicating that cells yet to become tetraploid have nonetheless suered irreversible genomic and/or mitotic spindle damage. In the face of normal p53 function, such damage would either be repaired or trigger apoptotis. We propose that loss of p53 and overexpression of c-myc permits the emergence and survival of cells with increasingly severe damage and the eventual development of tetraploidy.
Introduction
A role for the p53 tumor suppressor protein in maintaining genomic integrity is now well established (Hartwell and Kastan, 1994; Jacks and Weinberg, 1996; Ko and Prives, 1996) . Inactivation of p53 renders cells more susceptible to gene ampli®cation and the development of aneuploidy (Levine et al., 1991; Livingstone et al., 1992; Hartwell and Kastan, 1994; Jacks and Weinberg, 1996; Ko and Prives, 1996) . In part, this results from loss of a G1 checkpoint which normally prevents the replication of damaged or fragmented DNA (Kastan et al., 1991; DiLeonardo et al., 1994; Jacks and Weinberg, 1996; Ko and Prives, 1996) . More recently p53-dependent G2 and M checkpoints have been identi®ed (Agarwal et al., 1995; Cross et al., 1995; Pellegata et al., 1996; Waldman et al., 1996) . In the absence of functional p53, cells arrested either in G2 or M by metabolic inhibitors undergo additional rounds of S-phase, without intervening mitoses, eventually resulting in the accumulation of cells with a polyploid DNA content (Cross et al., 1995; Waldman et al., 1996) .
Little is known regarding the means by which polyploidy or aneuploidy is generated in the absence of functional p53. However, proteins whose overexpression promotes unscheduled DNA synthesis might be logical candidates for this function. c-myc is normally expressed as an immediate-early response gene whose product is necessary for the G1?S transition (Kelly et al., 1983; Armelin et al., 1984; Prochownik et al., 1988; Eilers et al., 1991) . Furthermore, the conditional expression of c-myc is sucient to induce S-phase in quiescent cells (Armelin et al., 1984; Eilers et al., 1991) . Therefore, we tested the idea that deregulated expression of c-myc, coupled with inactivation of endogenous p53, would result in a more profound loss of cell cycle control and an enhanced predisposition to the development of polyploidy. As demonstrated here, diploid cells are highly susceptible to the development of tetraploidy when c-myc oncoprotein overexpression is coupled with p53 inactivation. c-myc appears to be unique in this regard as neither N-myc nor L-myc were able to promote tetraploidy. Our results argue that the inherent genomic instability which ensues as a result of p53 inactivation is greatly accentuated by the co-expression of c-myc.
Results

c-myc promotes tetraploidy in cells lacking p53
32D cells are a diploid murine myeloid cell line which require interleukin-3 (IL-3) for their growth and survival and which express wild-type p53 (Greenberger et al., 1983; Valtieri et al., 1987; Blandino, 1995) . Cell lines stably expressing c-myc, N-myc or Lmyc (Zhang et al., 1997; Nesbit et al., in press) were re-transfected with an expression vector for the E6 protein from an oncogenic human papilloma virus (HPV-16). The E6 gene product, which is necessary for the transformation of epithelial cells or ®broblasts by HPV (Farthing and Vousden, 1994; Tommasino and Crawford, 1995; Vousden, 1995; Barbosa, 1996) , binds to p53 and promotes its ubiquitin-dependent degradation (Schener et al., 1990 (Schener et al., , 1993 Werness et al., 1990; Huibregste et al., 1994) . As shown in Figure 1a , all four cell lines transfected with the E6 expression vector contained equivalent levels of E6 transcripts. No E6 transcripts were detected in control cultures transfected with the empty parental vector.
To determine the eect of E6 expression on p53 protein levels, cultures were treated for 12 h with Adriamycin, a potent inducer of p53 (Nelson and Kastan, 1994) . As seen in Figure 1b , Western blots of cellular lysates showed that p53 protein was induced to equivalent levels in all control cell lines but was either absent or barely detectable in those which expressed E6. To assess the biological consequences of reduced p53 levels, logarithmically growing cultures were exposed to a 137 Cs g-ray source and their cell cycle distribution determined 24 h later by¯uorescence-activated cell sorting (FACS) of propidium iodidestained nuclei. g-irradiation has been previously shown to induce a p53-dependent cell cycle arrest in G1, whereas in the absence of functional p53, irradiated cells arrest in G2/M instead (Kuerbitz et al., 1992; O'Connor et al., 1993) . Prior to irradiation, all logarithmically growing cell lines showed similar cell cycle pro®les (Table 1 , lines 1 ± 8). A small but reproducible fraction of c-myc+E6 cells also contained 44N DNA content (line 6). Following irradiation, all control cell lines displayed a strong arrest in G1 and G2 with a concomitant reduction in the fraction of cells in S-phase (Table 1 , lines 9 ± 12). In contrast, all g-irradiated E6-expressing cell lines bypassed the G1 cell cycle block and arrested instead at G2/M (lines 13 ± 16). Together with the results shown in Figure 1 , these experiments indicate that E6 abrogated the p53-dependent block to cell cycle progression that is a consequence of g-irradiationinduced DNA damage.
With continued in vitro passage, cells with 44N DNA content continued to emerge from the c-myc+E6 cultures, eventually becoming the dominant population ( Figure 2a) . In contrast, c-myc+puro and neo+E6 cell lines retained their diploid DNA content. FACS analyses performed on isolated nuclei were indistinguishable from those performed with whole cells indicating that the tetraploid pro®le of c-myc+E6 cells was not the result of heterokaryon formation. This was con®rmed by Wright ± Giemsa-staining and visual microscopy which showed that 51% of the nonmitotic population contained more than one nucleus per cell (not shown). FACS analysis of g-irradiated late passage c-myc+E6 cells showed the presence of prominent G1-and G2/M-arrested populations with mostly 4N and 8N DNA content. Karyotypic analysis Cs source at a rate of 5 Gy/min) (rows 9 ± 16). Cells were then re-cultured in standard medium (Zhang et al., 1997) for 24 h at which time they were ®xed in ethanol, stained with propidium iodide, and analysed by FACS as previously described (Zhang et al., 1997) . The results shown here are the average of 3 ± 5 separate determinations, with standard errors 55% of late-passage c-myc+E6 cultures con®rmed their tetraploid status (Figure 2b and c) .
The foregoing results demonstrated that the combination of c-myc and E6 overexpression predisposed diploid cells to the development of tetraploidy. Although it seemed likely that this was the result of E6-mediated inactivation of p53 (Figure 1) , it was formally possible that other known functions of E6 (Farthing and Vousden, 1994; Tommasino and Crawford, 1995; Vousden, 1995; Barbosa, 1996) were involved, perhaps even to the exclusion of p53 inactivation. To address this, we selectively inactivated endogenous p53 in neo or c-myc cells with a dominant negative, temperature-sensitive mutant of p53 (tsp53) (Michalovitz et al., 1990; Ryan et al., 1994) . Western blots of extracts from c-myc+tsp53 cells con®rmed the expression of large amounts of the mutant protein ( Figure 3a ). These cells also failed to arrest in G1 following exposure to a sublethal dose of g-irradiation ( Figure 3b and data not shown). Similar to c-myc+E6 cells, c-myc+tsp53 cells also became tetraploid after more than 20 in vitro passages ( Figure 3c ). This was not seen either in control neo+tsp53 or in c-myc cells transfected with an empty hygromycin vector. Further con®rmation that the development of tetraploidy was dependent upon p53 inactivation was obtained in 32D-c-myc cells transfected with vectors expressing two mutant E6 proteins incapable of binding p53 or promoting its degradation . Although each of the mutant E6 genes was expressed at levels comparable to that of wild-type E6, neither abrogated the G1 checkpoint block following g- irradiation nor promoted tetraploidy when co-expressed with c-myc (not shown).
Deregulation of cyclin B/cdc2 is associated with the acquisition of tetraploidy
An increase in cyclin B and its associated cdc2 kinase, has been reported in ®broblasts lacking functional p53 and preceeds the attenuation of the G2/M checkpoint and the development of aneuploidy (Walker et al., 1995; Kaufmann, 1997) . To determine whether cyclin B/cdc2 deregulation had occurred in tetraploid cmyc+E6 cells, the subunit composition of the complex was evaluated by immunoblotting, and cdc2 kinase activity was assayed on immunoprecipitates (Datta et al., 1996) . In comparison to neo+puro cells, cyclin B levels in neo+E6 and c-myc+puro were modestly elevated (Figure 4a ). In contrast a much greater amount of cyclin B was detected in c-myc+E6 cells. Levels of the cdc2 apoenzyme were equivalent in all cell lines. Consistent with their increased cyclin B levels, myc+E6 cells also contained increased cdc2 H1 histone kinase activity (Figure 4a ).
To determine whether cyclin B/cdc2 was properly regulated, neo+E6 and control neo+puro cells were separated into cell cycle-speci®c populations by counter¯ow centrifugal elutriation (Datta et al., 1996) and assayed as described above (Figure 4b ). These results showed that tetraploid c-myc+E6 cells with 4N DNA content express low levels of cyclin B and cdc2 kinase, consistent with the interpretation that they are in G0/G1. In contrast, cells with 8N DNA content showed elevated levels of cyclin B and cdc2 kinase activity, indicating that they are in G2/M. Thus, in comparison to other control cell lines, tetraploid cmyc+E6 cells demonstrate overexpression of otherwise normally regulated cyclin B/cdc2 kinase.
Premature induction of tetraploidy and irreversible damage in diploid cells
One of the questions pertaining to the foregoing results in both c-myc+E6 cells and c-myc+tsp53 cells is why they require such a prolonged period of in vitro culture prior to developing tetraploidy. One possible explanation is that each cell in the population has a small but equal probability of becoming tetraploid during each traversal of the cell cycle (the`stochastic model'). The time to the development of complete tetraploidy in the population would thus re¯ect the period needed for all of its individual cells to assume that state. A second model postulates that there exists a small subpopulation of cells with additional mutations which collaborate with c-myc in the absence of functional p53 to promote tetraploidy and impart a small growth advantage (the`mutation model'). The period leading to the development of 100% tetraploidy would thus re¯ect the time required for this subpopulation to replace its diploid counterpart.
Several studies were performed to distinguish between these two models. In the ®rst case, early passage, diploid c-myc+E6 cells, as well as cmyc+puro, neo+E6, and neo+puro control cells were treated with Nocodazole, a mitotic spindle poison which has previously been shown to induce tetraploidy in cells lacking p53 or its downstream eector p21 WAF1/CIP1 (Cross et al., 1995; Waldman et al., 1996) . We reasoned that, if the stochastic model were correct, c-myc+E6 cells might be more predisposed to the development of tetraploidy than neo+E6 cells. That this was indeed the case is shown if Figure 5 . In three separate experiments, 30 ± 50% of c-myc+E6 cells assumed a tetraploid state following a 16 h treatment with Nocodazole as opposed to 12 ± 20% of neo+E6 cells treated in parallel. In contrast, none of the control neo+puro cells became tetraploid. Surprisingly, we found that tetraploidy was also induced in cmyc+puro cells to the same extent as in neo+E6 cells. This indicated that, under the conditions of this experiment, the deregulated expression of c-myc could mimic the loss or inactivation of p53 by compromising the G2/M checkpoint resulting in DNA re-replication in the absence of an intervening mitosis. It also provided evidence in favor of the stochastic model by suggesting that a substantial fraction, if not all, of the cells were capable of becoming tetraploid under the proper conditions. Similar results were obtained with two other mitotic spindle poisons, Taxol and Colcemid, and in cells expressing tsp53 instead of E6 (not shown). Immunoblot analysis and kinase activity of cyclin B and cdc2 in unfractionated cells. 50 mg of whole cell lysate from the indicated lines was electrophoresed in each lane. Following transfer, blots were probed with antibodies against cyclin B or cdc2 (top and middle panels, respectively). cdc2 kinase assays were performed as previously described (Datta et al., 1996) using H1 histone as the substrate (bottom panel). The 32D-c-myc+E6 cultures used contained 490% tetraploid cells. (b) Immunoblot and H1 histone kinase activity of cyclin B and cdc2 in speci®c cell cycle populations of 32D-c-myc+E6 (490% tetraploid) or 32D-neo+puro cells isolated by counter¯ow centrifugation (Datta et al., 1996) . U: unfractionated cells; G0/G1: population of 490% pure G0/G1 phase cells; S: 4population of 490% pure S-phase cells; G2: population of 490% G2/M phase cells In a second series of experiments designed to distinguish between the stochastic and mutation models, early passage (diploid) and late passage (tetraploid) c-myc+ tsp53 cells as well as each of the control cell lines were cultured at 32.58C, a temperature permissive for p53 to assume its wild-type conformation (Michalovitz et al., 1990) . Under these conditions, neo+puro, c-myc+puro, and neo+tsp53 cells showed only a modest loss of viability over the 3 day course of the experiment (Figure 6 ). In contrast, both early and late passage c-myc+tsp53 cells showed a progressive loss of viability that was of an apoptotic nature (Figure 6b) . From these experiments, we conclude that, despite the fact that they have not yet become tetraploid, the majority of early passage cmyc+tsp53 cells are recognized as having suered irreparable damage and are eliminated by apoptotic mechanisms when the activity of p53 is restored.
Finally, strong support for a stochastic model was obtained from single-cell clones derived from pooled populations of stably transfected cells. Twelve of 12 cmyc+E6 clones and nine of 10 c-myc+tsp53 clones eventually developed tetraploidy (not shown).
Discussion
Fibroblasts from p53 null mice initially possess a diploid karotype and become aneuploid only after several weeks of in vitro propagation (Harvey et al., 1993) . Similarly expression of HPV16 E6 in primary human ®broblasts or epithelial cells frequently leads to the development of chromosomal breaks, DNA ampli®cation and aneuploidy Oda et al., 1996; Coursen et al., 1997) . However, this requires prolonged in vitro passage and is not seen in every cell (Oda et al., 1996) . Altogether, these observations suggest that other, as yet unidenti®ed, cellular genes may contribute to the loss of genomic integrity following the functional inactivation of p53. We show here that c-myc may be one such gene by virtue of the fact that its overexpression markedly enhances the acquisition of spontaneous tetraploidy in cells lacking functional p53. This does not appear to be a feature restricted to 32D cells as we have obtained similar ®ndings in two diploid murine ®broblast lines, one of which was derived from a p53 null animal (LEG and EVP, unpublished observations).
In contrast to observations made mostly in ®broblasts and epithelial cells (Levine et al., 1991; Carder et al., 1993; Blount et al., 1994; Purdie et al., 1994; Oda et al., 1996; Coursen et al., 1997) , 32D cells expressing either E6 or tsp53 retain a stable, diploid genotype for long periods of time (Figures 2, 3 , 5 and our unpublished observations). This may re¯ect the fact that 32D cells are already immortalized and/or that polyploidy following p53 inactivation is more commonly seen in cells of non-hematopoietic origin. Nonetheless, the enforced expression of c-myc against a p53 null background leads to the eventual development of tetraploidy in virtually 100% of the cells over a 12 ± 16 week period. Thus, it is clear that c-myc provides a necessary and potent stimulus for the development of tetraploidy in the concurrent absence of p53. This appears to be independent of any growth-promoting eect of c-myc since, under the conditions of our experiments, the presence of deregulated c-myc did not aect the growth properties of 32D cells (Figures 2, 3 and 5 and our unpublished observations). Numerous other groups have established that c-myc-overexpressing cells enjoy a proliferative advantage only under conditions where growth factors are limiting (Sorrentino et al., 1986; Stern et al., 1986; Karn et al., 1989) .
During the course of our studies, we noted that neither N-myc nor L-myc, despite being expressed at levels equal to that of c-myc (Nesbit et al., in press ), failed to promote tetraploidy when expressed in 32D Figure 5 Induction of tetraploidy by Nocodazole. The indicated pooled, early passage cell lines were ®rst examined by FACS to ensure that they were completely diploid in appearance and possessed similar cell cycle pro®les (top row). Following a 16 h exposure to Nocodazole (50 ng/ml), FACS was repeated (bottom row). Note that control neo+puro cells were nearly completely arrested in G2/M whereas 12 ± 20% of c-myc+puro and neo+E6 cells developed tetraploidy. In contrast up to 50% of early passage c-myc+E6 cells became terraploid. Similar results were obtained with early and late passage c-myc+tsp53 cells and with two other mitotic spindle poisons, Taxol and Colcemid (not shown) Figure 6 Induction of apoptosis in c-myc+tsp53 cells following restoration of wild-type p53 function. On the left, the indicated, logarithmically growing cell lines (495% viability) were ®rst evaluated by FACS to con®rm their diploid nature ( Figure 5 and data not shown). Early passage c-myc+tsp53 (495% diploid) were used 4 weeks after establishment whereas late passage cmyc+tsp53 cells (490% tetraploid) were used at 420 weeks after establishment. Cells were propagated at 38.58C and then seeded at a density of 10 5 /ml and maintained at 32.58C. cells with E6 or tsp53. This suggests that there exist fundamental dierences among these three oncoproteins with respect to their eects on genomic instability. How this relates to other dierences that have been reported (Birrer et al., 1988; Barrett et al., 1992; Prochownik and VanAntwerp, 1993; Nesbit et al., in press) remains to be established.
One viral gene that collaborates with HPV E6 to promote genomic instability is HPV E7, and at least one recent report has indicated that mass cultures of human bronchial epithelial cells that co-express E6 and E7 develop a more pronounced aneuploidy than do cultures expressing E6 alone (Coursen et al., 1997) . Several features of c-myc and HPV-E7 suggest similarities in the means by which they regulate the cell cycle. For example, E7 binds pRb, the retinoblastoma tumor suppressor, as well as the pRb-related protein p107 (reviewed in Vousden, 1995) . This promotes the release and activation of members of the E2F family of transcription factors which are necessary for the G1?S transition (Weinberg, 1995) . E2F1 has also been shown to up-regulate the transcription of Bmyb (Lam et al., 1994) and possibly of c-myc (Hiebert et al., 1989) . It is notable that E2F1, B-myb and c-myc are the only three known cellular genes whose overexpression can induce S-phase entry in quiescent cells (Eilers et al., 1991; Johnson et al., 1993; Qin et al., 1994; Sala et al., 1996) . Not surprisingly, HPV E7 itself also promote S-phase entry and allows cells to override the p53-mediated cell cycle arrest associated with DNA damage (Banks et al., 1990) .
Based on the above similarities among c-myc, Bmyb, E2F1 and HPV E7, it is tempting to suggest that c-myc provides a stimulus for unscheduled S-phases, perhaps associated with DNA damage. Normally, cells with wild-type p53 would detect such damage and either undergo DNA repair or trigger apoptosis, thus preventing the generation of aneuploidy or tetraploidy. The inactivation of p53, however, would permit the survival of abnormal cells due to loss of an essential apoptotic pathway. The additional abrogation of checkpoint function at the G1 and G2/M phases of the cell cycle (Table 1 and Figure 4 ) might also allow an acceleration of the rate at which genomically altered cells were generated. Certainly the results presented in Figure 6 are consistent with these notions. Indeed, they suggest that, in the absence of functional p53, c-myc overexpression, even prior to the development of tetraploidy, results in sucient damage so as to relegate the cell to an apoptotic fate following the reinstatement of p53 function. Despite this behavior however, as well as the above cited similarity to HPV E7, we cannot yet be certain that apoptosis actually occurs as a result of direct DNA damage. Indeed, the experiments presented in Figure 5 would argue that cmyc overexpression and p53 loss share a common consequence, namely, the uncoupling of mitosis and subsequent S-phase initiation. By analogy with previous ®ndings in p53 null settings, these new experiments suggest a posssible role for c-myc in maintaining the integrity of the mitotic spindle. Whether c-myc's role in promoting the development of tetraploidy is due to direct genomic damage, mitotic spindle disruption, the ability to promote unscheduled S-phase, or some combination of these requires further investigation.
The results presented here identify a heretofore unrecognized function of c-myc, namely the generation of tetraploidy in the absence of functional p53. These ®ndings provide a potential explanation as to why naturally occurring tumors with deregulated c-myc are frequently associated with p53 mutations that may portend a worse prognosis (Farrell et al., 1991; Gaidano et al., 1991; Wiman et al., 1991; Ballerini et al., 1993; Berns et al., 1996) .
Materials and methods
Expression plasmids
The construction and characterization of the pSVLneo-cmyc expression vector has been previously described (Zhang et al., 1997) . For the construction of N-myc and L-myc vectors, cDNAs encoding the entire coding region were excised from their respective vectors (Prochownik and VanAntwerp, 1993) and cloned into the parental pSVLneo vector. Plasmid DNAs were puri®ed on Qiagen columns (Chatsworth, CA, USA). The HPV-16 E6 expression plasmid was constructed by excising an approximately 700 bp BamHI fragment from a pBluescript-E6 vector (gift of S Fan) followed by blunt-end repair with the Klenow fragment of DNA polymerase I and ligation into the bluntended EcoRI site of the pAPuro expression vector (Takata et al., 1994) . Mutant E6 genes (gift of K Vousden) consisted of 16E6D106 ± 110 and 16E6D111 ± 115 . Each gene was ampli®ed by PCR, using primers with terminally engineered EcoRI restriction sites. Following EcoRI digestion of the ampli®ed products, they were puri®ed by agarose gel electrophoresis and cloned into the pAPuro vector.
Cell lines
Standard culture conditions for 32D cells consisted of RPMI medium supplemented with 10% fetal bovine serum (Hyclone, Logan, UT, USA), 2 mM glutamine, 100 units/ ml Penicillin G, 100 mg/ml streptomycin (GIBCO ± BRL), and 10% conditional medium from an IL-3-producing cell line (Zhang et al., 1997) . Transfected cultures were maintained at all times in G418 (500 mg/ml) and/or Puromycin (1 mg/ml) in a humidi®ed 5% C0 2 atmosphere at 378C. To obtain stable cell lines expressing myc oncoproteins, 5 mg of NdeI-linearized plasmid DNA was electroporated into 2610 7 cells followed by selection in G-418 (GIBCO ± NRL, Grand Island, NY, USA) as previously described (Zhang et al., 1997) . G-418-resistant clones were pooled and used in all subsequent studies. The cell lines were designated neo, c-myc, N-myc and L-myc. Northern and western blotting showed that each cell line expressed RNA transcripts and myc oncoproteins of the expected size and type (Nesbit et al., in press ). pAPuro-E6 or pAPuro parental vector DNAs were linearized with NotI, transfected into the above cell lines by electroporation and selected in 1 mg/ml of Puromycin (Sigma, St Louis, MO, USA). The resultant pooled cells were designated as above except with the added designatioǹ puro' or`E6' to indicate stable transfection with either the control or E6 expression vector, respectively. The plasmid pLTRtsp53-Hygro (Michalovitz et al., 1990; Ryan et al., 1994) , or the empty parental vector, was linearized with BamHI and stably introduced into neo or c-myc cell lines. Selection was in 400 mg/ml Hygromycin (GIBCO ± BRL) at 38.58C to allow maintainence of the mutant p53 conformation.
Clonal cell lines were derived by limiting dilution in 96 well tissue culture plates.
Northern and Western blotting
Northern analyses were performed as previously described (Zhang et al., 1997) using full length, 32 P-radiolabeled E6 DNA as a probe. Western blot analyses were performed as described (Langlands and Prochownik, 1997) . After treatment with Adriamycin, cells were washed twice with PBS and lysed in SDS ±PAGE buer. 25 mg of total protein was resolved by SDS ± PAGE (10% polyacrylamide), transferred to a PVDF membrane by electroblotting and probed with an anti-p53 monoclonal antibody (Ab-1, Calbiochem, LaJolla, CA, USA). Antibodies against cyclin B (# 14541A) and cdc2 (#SC-54) were obtained from Pharmingen (San Diego, CA, USA) and Santa Cruz Biotechnology (Santa Cruz, CA), respectively and used according to the directions of the supplier. Blots were developed using a Renaissance enhanced chemiluminescence kit (New England Nuclear, Boston, MA, USA) according to the directions provided by the supplier.
